1.
Salinas Alva E, Poquioma Rojas E, Hinojosa Ramírez R. Management of hormonal therapy for the treatment of advanced hormone-dependent prostate cancer: A pharmacoeconomics assessment of the use of Degarelix – Firmagon® compared to generic triptorelin. Acta Med Peru [Internet]. 2024May20 [cited 2024Nov.24];28(4):188-93. Available from: http://54.39.98.165/index.php/AMP/article/view/1118